SCHEMBL6471117

SCHEMBL6471117

COc1cc(C=O)cc(C)c1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.50
▸ TSHR P16473 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ TRIM24 O15164 1/20 0.46
▸ ALDH5A1 P51649 1/20 0.46
▸ ABAT P80404 1/20 0.46
▸ TRIM33 Q9UPN9 1/20 0.46
▸ FDPS P14324 1/20 0.43
▸ AOX1 Q06278 1/20 0.42
▸ TUBB1 Q9H4B7 3/20 0.41
▸ SRC P12931 1/20 0.41
▸ TTR P02766 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A3 P47895 1/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ PTGES O14684 1/20 0.37
▸ ALOX5 P09917 1/20 0.37
▸ PTGS1 P23219 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11594562 0.88 ALDH1A1 (0.57) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL493981 0.85 SRC (0.45) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL29411737 0.82 ALDH1A1 (0.52) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL5200065 0.82 ALDH1A1 (0.52) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL111326 0.80 ALDH1A1 (0.53) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL5045913 0.78 ALDH1A1 (0.52) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL973079 0.77 ALDH1A1 (0.59) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL5476629 0.77 EGFR (0.58) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL29952164 0.77 EGFR (0.58) ALDH1A1TSHRTDP1HPGDTRIM24
SCHEMBL13512685 0.77 ALDH1A1 (0.50) ALDH1A1TSHRTDP1HPGDTRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065171-A1 Substituted purine derivatives ARIAD PHARMACEUTICALS, INC. 2005-03-24 — — US disclosed
WO-2005009348-A2 SUBSTITUTED PURINE DERIVATIVES ARIAD PHARMACEUTICALS, INC. (US) 2005-02-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065171-A1 Substituted purine derivatives ADORA2A, PNP, HPRT1 ALDH1A1 611/4885TSHR 566/4885TDP1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback